LIAISON CMV IgG II - SFDA Registration ME0000003094SFDAA00057
Access comprehensive regulatory information for LIAISON CMV IgG II in the Saudi Arabia medical device market through Pure Global AI's free database. This Annex II List B device is registered with Saudi Arabia SFDA under registration number ME0000003094SFDAA00057 and manufactured by DiaSorin S.p.A..
This page provides complete registration details including product category (Chemicals), manufacturer information, model details, and regulatory compliance data from the official Saudi Arabia SFDA medical device database. Pure Global AI offers free access to Saudi Arabia's complete medical device registry, helping global MedTech companies navigate SFDA regulations efficiently.
IVD Kit for determination of specific IgG antibodies to hCMV in human serum or plasma
The LIAISON® CMV IgG II assay uses chemiluminescent immunoassay (CLIA) technology for the quantitative determination of specific IgG antibodies to hCMV in human serum or plasma samples. The test has to be performed on the LIAISON® analyzer family.
[]